Literature DB >> 29378848

A major isoform of the E3 ubiquitin ligase March-I in antigen-presenting cells has regulatory sequences within its gene.

Sunil Kaul1, Sharad K Mittal1, Paul A Roche2.   

Abstract

Regulation of major histocompatibility complex class II (MHC-II) expression is important not only to maintain a diverse pool of MHC-II-peptide complexes but also to prevent development of autoimmunity. The membrane-associated RING-CH (March) E3 ubiquitin ligase March-I regulates ubiquitination and turnover of MHC-II-peptide complexes in resting dendritic cells (DCs) and B cells. However, activation of either cell type terminates March-I expression, thereby stabilizing MHC-II-peptide complexes. Despite March-I's important role in the biology of antigen-presenting cells (APCs), how expression of March-I mRNA is regulated remains unknown. We now show that both DCs and B cells possess a distinct isoform of March-I whose expression is regulated by a promoter located within the March-I gene. Using March-I promoter fragments to drive expression of GFP, we also identified a core promoter for expression of March-I in DCs and B cells, but not in fibroblasts, kidney cells, or epithelial cells, that contains regulatory regions that down-regulate March-I expression upon activation of DCs. Curiously, we found downstream sequence elements, present in the first coding exon of March-I in APCs, that confer regulation of March-I expression in activated APCs. In summary, our study identifies regulatory regions of the March-I gene that confer APC-specific expression and activation-induced modulation of March-I expression in DCs and B cells.

Entities:  

Keywords:  antigen presentation; dendritic cell; gene regulation; intragenic promoter; major histocompatibility complex (MHC); ubiquitin ligase

Mesh:

Substances:

Year:  2018        PMID: 29378848      PMCID: PMC5868253          DOI: 10.1074/jbc.RA118.001775

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Transport of peptide-MHC class II complexes in developing dendritic cells.

Authors:  S J Turley; K Inaba; W S Garrett; M Ebersold; J Unternaehrer; R M Steinman; I Mellman
Journal:  Science       Date:  2000-04-21       Impact factor: 47.728

2.  Lentivirus vectors incorporating the immunoglobulin heavy chain enhancer and matrix attachment regions provide position-independent expression in B lymphocytes.

Authors:  Carolyn Lutzko; Dinithi Senadheera; Dianne Skelton; Denise Petersen; Donald B Kohn
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 3.  Core promoters in transcription: old problem, new insights.

Authors:  Ananda L Roy; Dinah S Singer
Journal:  Trends Biochem Sci       Date:  2015-02-10       Impact factor: 13.807

4.  Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells.

Authors:  Günther Baravalle; Hyesuk Park; Megan McSweeney; Mari Ohmura-Hoshino; Yohei Matsuki; Satoshi Ishido; Jeoung-Sook Shin
Journal:  J Immunol       Date:  2011-08-17       Impact factor: 5.422

5.  CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation.

Authors:  Lina E Tze; Keisuke Horikawa; Heather Domaschenz; Debbie R Howard; Carla M Roots; Robert J Rigby; David A Way; Mari Ohmura-Hoshino; Satoshi Ishido; Christopher E Andoniou; Mariapia A Degli-Esposti; Christopher C Goodnow
Journal:  J Exp Med       Date:  2011-01-10       Impact factor: 14.307

6.  MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation.

Authors:  Aude De Gassart; Voahirana Camosseto; Jacques Thibodeau; Maurizio Ceppi; Nadia Catalan; Philippe Pierre; Evelina Gatti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

7.  Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells.

Authors:  Mari Ohmura-Hoshino; Yohei Matsuki; Mari Mito-Yoshida; Eiji Goto; Masami Aoki-Kawasumi; Manabu Nakayama; Osamu Ohara; Satoshi Ishido
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

8.  The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.

Authors:  K Inaba; S Turley; T Iyoda; F Yamaide; S Shimoyama; C Reis e Sousa; R N Germain; I Mellman; R M Steinman
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

9.  The Ensembl gene annotation system.

Authors:  Bronwen L Aken; Sarah Ayling; Daniel Barrell; Laura Clarke; Valery Curwen; Susan Fairley; Julio Fernandez Banet; Konstantinos Billis; Carlos García Girón; Thibaut Hourlier; Kevin Howe; Andreas Kähäri; Felix Kokocinski; Fergal J Martin; Daniel N Murphy; Rishi Nag; Magali Ruffier; Michael Schuster; Y Amy Tang; Jan-Hinnerk Vogel; Simon White; Amonida Zadissa; Paul Flicek; Stephen M J Searle
Journal:  Database (Oxford)       Date:  2016-06-23       Impact factor: 3.451

10.  Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection.

Authors:  Haiyin Liu; Reema Jain; Jing Guan; Vivian Vuong; Satoshi Ishido; Nicole L La Gruta; Daniel H Gray; Jose A Villadangos; Justine D Mintern
Journal:  J Exp Med       Date:  2016-08-08       Impact factor: 14.307

View more
  4 in total

1.  The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation.

Authors:  Jian Wu; Lu Xia; Xiangyu Yao; Xiao Yu; Keyla C Tumas; Wenxiang Sun; Yang Cheng; Xiao He; Yu-Chih Peng; Brajesh K Singh; Cui Zhang; Chen-Feng Qi; Silvia Bolland; Sonja M Best; Channe Gowda; Ruili Huang; Timothy G Myers; Carole A Long; Rong-Fu Wang; Xin-Zhuan Su
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-30       Impact factor: 11.205

Review 2.  MHC class II fine tuning by ubiquitination: lesson from MARCHs.

Authors:  Satoshi Ishido; Mizuho Kajikawa
Journal:  Immunogenetics       Date:  2018-10-31       Impact factor: 2.846

3.  Induced overexpression of MARCH-1 in human macrophages altered to M2 phenotype for suppressing inflammation process.

Authors:  Zivar Zangeneh; Gholamreza Khamisipour; Ali Reza Andalib
Journal:  Iran J Basic Med Sci       Date:  2022-04       Impact factor: 2.532

4.  Physiological substrates and ontogeny-specific expression of the ubiquitin ligases MARCH1 and MARCH8.

Authors:  Patrick Schriek; Haiyin Liu; Alan C Ching; Pauline Huang; Nishma Gupta; Kayla R Wilson; MinHsuang Tsai; Yuting Yan; Christophe F Macri; Laura F Dagley; Giuseppe Infusini; Andrew I Webb; Hamish E G McWilliam; Satoshi Ishido; Justine D Mintern; Jose A Villadangos
Journal:  Curr Res Immunol       Date:  2021-10-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.